AAAAAA
Results:
1-13
|
Results: 13
Authors:
Suryapranata, H
Ottervanger, JP
Nibbering, E
van't Hof, AW
Hoorntje, JCA
de Boer, MJ
Al, MJ
Zijlstra, F
Citation: H. Suryapranata et al., Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction, HEART, 85(6), 2001, pp. 667-671
Authors:
Akkerhuis, KM
van den Brand, MJBM
van der Zwaan, C
Peels, HOJ
Suryapranata, H
van der Wieken, LR
Stibbe, J
Hoffmann, J
Baardman, T
Deckers, JW
Simoons, ML
Citation: Km. Akkerhuis et al., Pharmacodynamics and safety of lefradafiban, an oral platelet glycoproteinIIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty, HEART, 85(4), 2001, pp. 444-450
Authors:
Zeymer, U
Suryapranata, H
Monassier, JP
Opolski, G
Davies, J
Rasmanis, G
Linssen, G
Tebbe, U
Schroder, R
Tiemann, R
Maching, T
Neuhaus, KL
Citation: U. Zeymer et al., The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusiontherapy for acute myocardial infarction - Results of the evaluation of thesafety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial, J AM COL C, 38(6), 2001, pp. 1644-1650
Authors:
Ottervanger, JP
van't Hof, AWJ
Reiffers, S
Hoorntje, JCA
Suryapranata, H
de Boer, MJ
Zijlstra, F
Citation: Jp. Ottervanger et al., Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction, EUR HEART J, 22(9), 2001, pp. 785-790
Authors:
Foley, DP
Pieper, M
Wijns, W
Suryapranata, H
Grollier, G
Legrand, V
de Scheerder, I
Hanet, C
Puel, J
Mudra, H
Bonnier, HJRM
Colombo, A
Thomas, M
Probst, P
Morice, MC
Kleijne, J
Serruys, PW
Citation: Dp. Foley et al., The influence of stent length on clinical and angiographic outcome in patients undergoing elective stenting for native coronary artery lesions - Final results of the Magic 5L Study, EUR HEART J, 22(17), 2001, pp. 1585-1593
Authors:
Liem, A
Zijlstra, F
Ottervanger, JP
Hoorntje, JCA
Suryapranata, H
de Boer, MJ
Verheugt, FWA
Citation: A. Liem et al., High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: The Heparin in Early Patency (HEAP) randomized trial, J AM COL C, 35(3), 2000, pp. 600-604
Authors:
Widimsky, P
Groch, L
Zelizko, M
Aschermann, M
Bednar, F
Suryapranata, H
Citation: P. Widimsky et al., Multicentre randomized trial comparing transport to primary angioplasty vsimmediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory - The PRAGUE study, EUR HEART J, 21(10), 2000, pp. 823-831
Authors:
Ruygrok, PN
Melkert, R
Morel, MAM
Ormiston, JA
Bar, FW
Fernandez-Aviles, F
Suryapranata, H
Dawkins, KD
Hanet, C
Serruys, PW
Citation: Pn. Ruygrok et al., Does angiography six months after coronary intervention influence management and outcome?, J AM COL C, 34(5), 1999, pp. 1507-1511
Authors:
van 't Hof, AWJ
Liem, AL
de Boer, MJ
Hoorntje, JCA
Suryapranata, H
Zijlstra, F
Citation: Awj. Van 'T Hof et al., A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction, EUR HEART J, 20(9), 1999, pp. 659-665
Authors:
Serruys, PW
Foley, DP
Jackson, G
Bonnier, H
Macaya, C
Vrolix, M
Branzi, A
Shepherd, J
Suryapranata, H
de Feyter, PJ
Melkert, R
van Es, GA
Pfister, PJ
Citation: Pw. Serruys et al., A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty - Final results of the fluvastatin angiographic restenosis (FLARE) trial, EUR HEART J, 20(1), 1999, pp. 58-69
Authors:
Thomas, K
Ottervanger, JP
de Boer, MJ
Suryapranata, H
Hoorntje, JCA
Zijlstra, F
Citation: K. Thomas et al., Primary angioplasty compared with thrombolysis in acute myocardial infarction in diabetic patients, DIABET CARE, 22(4), 1999, pp. 647-649
Authors:
Zijlstra, F
Hoorntje, JCA
de Boer, MJ
Reiffers, S
Miedema, K
Ottervanger, JP
van't Hof, AWJ
Suryapranata, H
Citation: F. Zijlstra et al., Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction, N ENG J MED, 341(19), 1999, pp. 1413-1419
Authors:
Ottervanger, JP
Liem, A
de Boer, MJ
van't Hof, AWJ
Suryapranata, H
Hoorntje, JCA
Zijlstra, F
Citation: Jp. Ottervanger et al., Limitation of myocardial infarct size after primary angioplasty: Is a higher potency the only mechanism?, AM HEART J, 137(6), 1999, pp. 1169-1172
Risultati:
1-13
|